Odonate Therapeutics, Inc. (ODT) financial statements (2021 and earlier)

Company profile

Business Address 4747 EXECUTIVE DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments180139
Cash and cash equivalents180139
Prepaid expense 1
Other undisclosed current assets3 
Total current assets:184140
Noncurrent Assets
Operating lease, right-of-use asset2
Property, plant and equipment22
Restricted cash and investments10
Other noncurrent assets11
Total noncurrent assets:53
TOTAL ASSETS:189143
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2418
Accounts payable1611
Accrued liabilities97
Debt0 
Deferred rent credit 0
Total current liabilities:2518
Noncurrent Liabilities
Long-term debt and lease obligation2 
Operating lease, liability2
Liabilities, other than long-term debt 0
Deferred rent credit 0
Total noncurrent liabilities:20
Total liabilities:2719
Stockholders' equity
Stockholders' equity attributable to parent162124
Common stock00
Additional paid in capital402252
Accumulated deficit(240)(128)
Total stockholders' equity:162124
TOTAL LIABILITIES AND EQUITY:189143

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Operating expenses(115)(91)
Operating loss:(115)(91)
Loss before gain (loss) on sale of properties:(115)(91)
Other undisclosed net income32
Net loss available to common stockholders, diluted:(112)(89)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(112)(89)
Comprehensive loss, net of tax, attributable to parent:(112)(89)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: